TABLE 1

Characteristics and treatment data of multidrug-resistant tuberculosis (MDR-TB) patients

Patients
 Age years41 (29–49)
 Male26 (67)
 BMI kg·m−220.7 (20.0–22.6)
 ASAT IU·L−125 (18–33)
 ALAT IU·L−120 (11–27)
 QTc ms395 (368–413)
Tuberculosis
 MDR-TB26 (67)
 XDR-TB13 (33)
 Pulmonary39 (100)
 Sputum culture converted28 (72)
 Recurrence6 (15)
Clarithromycin
 500 mg once daily3 (8)
 750 mg once daily1 (3)
 1000 mg once daily35 (90)
 Total use days336 (183–526)
 Duration of TB treatment months18 (11–20)
  • Data are presented as median (interquartile range) or n (%). n=39. BMI: body mass index; ASAT: l-aspartate aminotransferase; ALAT: l-alanine aminotransferase; XDR: extensively drug-resistant.